C12Y 301/01008
Cholinesterase , i.e. butyrylcholine-esterase
Official title: Cholinesterase (3.1.1.8), i.e. butyrylcholine-esterase
C12Y301/01008 (Cholinesterase , i.e. butyrylcholine-esterase) appears on 47 US grants and 58 published applications in this corpus.
Search patents in C12Y- Granted patents
- 47
- Published applications
- 58
- Assignees
- 35
- Inventors
- 113
- Latest grant
- 24 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 3 | 3 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 2 | 0 |
| 2011 | 2 | 0 |
| 2012 | 3 | 1 |
| 2013 | 2 | 5 |
| 2014 | 3 | 4 |
| 2015 | 4 | 6 |
| 2016 | 4 | 8 |
| 2017 | 1 | 6 |
| 2018 | 1 | 0 |
| 2019 | 6 | 5 |
| 2020 | 0 | 1 |
| 2021 | 5 | 3 |
| 2022 | 2 | 0 |
| 2023 | 0 | 2 |
| 2024 | 5 | 3 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Systems and methods for engineering enzymes using identified energy transfer networks24 Jun 2025US 12,340,872 B2Arium BioLabs LLC
- Method for inhibiting enzyme activity using Boscia senegalensis22 Oct 2024US 12,121,555 B1King Faisal University
- Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin15 Oct 2024US 12,116,602 B2Mayo Foundation for Medical Education and Research
- Virus25 Jun 2024US 12,016,949 B2iosBio Ltd
- Mass spectrometry ionization based-assay for the detection of enzyme activity and/or presence27 Feb 2024US 11,913,059 B1The United States of America as represented by the Secretary of the Army
- Anti-ghrelin butyrylcholinesterase enzyme therapeutic19 Mar 2026US 2026/0077059 A1
- Biological product, method and application thereof5 Feb 2026US 2026/0035678 A1Shanghai Jenomed Biotech Co., Ltd.
- Protein and peptide delivery systems and methods for making and using them13 Nov 2025US 2025/0345442 A1San Diego State University (Sdsu) Foundation, Dba San Diego State University Research Foundation
- Virus14 Nov 2024US 2024/0374509 A1iosBio Ltd
- Downregulation of circulating ghrelin and therapeutic applications thereof24 Oct 2024US 2024/0350596 A1University of Kentucky Research Foundation
Most cited
By later US patents
- Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them116US 5,891,725 AYissum Research Development Co. of the Hebrew Univ. of Jerusalem · 1999
- Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use15US 7,049,121 B2Applied Molecular Evolution, Inc. · 2006
- Butyrylcholinesterase zwitterionic polymer conjugates13US 10,363,290 B2Kodiak Sciences Inc. · 2019
- High-activity mutants of butyrylcholinesterase for cocaine hydrolysis and method of generating the same9US 7,438,904 B1University of Kentucky Research Foundation · 2008
- Butyrylcholinesterase zwitterionic polymer conjugates8US 11,071,771 B2Kodiak Sciences Inc. · 2021